14034-96-9

Upstream product

• 59255-98-0 2-(tert-butyl)-4-nitroaniline 
• 151-50-8 potassium cyanide 

Downstream Products

• 1006898-93-6 4-amino-2-tert-butylbenzonitrile 
• 1533424-09-7 4-(5-amino-1H-[1,2,4]triazol-3-ylamino)-2-tert-butylbenzonitrile 
• 14035-00-8 4-Dimethylamino-2-tert.-butyl-benzoesaeure 
• 14034-98-1 4-Amino-2-tert.-butyl-benzoesaeure 
• 14034-99-2 4-Bromo-2-tert-butylbenzoic acid 
• 14035-01-9 2-(tert-butyl)-4-chlorobenzoic acid 
• 14034-97-0 4-Nitro-2-tert.-butyl-benzoesaeure 

Relevant academic research and scientific papers

TRIAZOLE COMPOUNDS AS ANTIVIRALS

The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts: Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.